Literature DB >> 15761496

Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS.

Christopher Kornfeld1, Mickaël J-Y Ploquin, Ivona Pandrea, Abdourahmane Faye, Richard Onanga, Cristian Apetrei, Virginie Poaty-Mavoungou, Pierre Rouquet, Jérôme Estaquier, Lorenzo Mortara, Jean-François Desoutter, Cécile Butor, Roger Le Grand, Pierre Roques, François Simon, Françoise Barré-Sinoussi, Ousmane M Diop, Michaela C Müller-Trutwin.   

Abstract

T cell activation levels in HIV infection are predictive of AIDS progression. We searched for the immunological correlates of protection against disease progression by studying the early stages of nonpathogenic SIV infection in African green monkeys (SIVagm). The African green monkeys (AGMs) displayed high peak viremias and a transient decline in levels of blood CD4(+) and CD8(+) T cells between days 5 and 17 after infection. A concomitant increase in levels of CD4(+)DR(+), CD8(+)DR(+), and CD8(+)CD28(-) cells was detected. After the third week, T cell activation returned to baseline levels, which suggested a protective downregulation of T cell activation. A very early (24 hours after infection) and strong induction of TGF-beta1 and FoxP3 expression was detected and correlated with increases in levels of CD4(+)CD25(+) and CD8(+)CD25(+) T cells. This was followed by a significant increase in levels of IL-10, whereas IFN-gamma gene upregulation was more transient, and levels of TNF-alpha and MIP-1alpha/beta transcripts did not increase in either blood or tissues. The profiles were significantly different during primary SIV infection in macaques (SIVmac); that is, there was a delayed increase in IL-10 levels accompanied by moderate and persistent increases in TGF-beta levels. Together, our data show that SIVagm infection is associated with an immediate antiinflammatory environment and suggest that TGF-beta may participate in the generation of Tregs, which may prevent an aberrant chronic T cell hyperactivation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761496      PMCID: PMC1062895          DOI: 10.1172/JCI23006

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.

Authors:  Liselotte van Asten; Figen Danisman; Sigrid A Otto; José A M Borghans; Mette D Hazenberg; Roel A Coutinho; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2004-09-24       Impact factor: 4.177

Review 2.  Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

3.  Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta.

Authors:  D D Taub; K Conlon; A R Lloyd; J J Oppenheim; D J Kelvin
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

4.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Authors:  Steven G Deeks; Christina M R Kitchen; Lea Liu; Hua Guo; Ron Gascon; Amy B Narváez; Peter Hunt; Jeffrey N Martin; James O Kahn; Jay Levy; Michael S McGrath; Frederick M Hecht
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

Review 5.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

6.  Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.

Authors:  Einar M Aandahl; Jakob Michaëlsson; Walter J Moretto; Frederick M Hecht; Douglas F Nixon
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

7.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.

Authors:  M Clerici; T A Wynn; J A Berzofsky; S P Blatt; C W Hendrix; A Sher; R L Coffman; G M Shearer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

8.  High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.

Authors:  Lisa LaFranco-Scheuch; Kristina Abel; Norbert Makori; Kristina Rothaeusler; Christopher J Miller
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more
  148 in total

1.  Immunovirological analyses of chronically simian immunodeficiency virus SIVmnd-1- and SIVmnd-2-infected mandrills (Mandrillus sphinx).

Authors:  Cristian Apetrei; Beth Sumpter; Sandrine Souquiere; Ann Chahroudi; Maria Makuwa; Patricia Reed; Ruy M Ribeiro; Ivona Pandrea; Pierre Roques; Guido Silvestri
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Accumulation of functionally immature myeloid dendritic cells in lymph nodes of rhesus macaques with acute pathogenic simian immunodeficiency virus infection.

Authors:  Viskam Wijewardana; Anthea L Bouwer; Kevin N Brown; Xiangdong Liu; Simon M Barratt-Boyes
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

3.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

4.  A five-year longitudinal analysis of sooty mangabeys naturally infected with simian immunodeficiency virus reveals a slow but progressive decline in CD4+ T-cell count whose magnitude is not predicted by viral load or immune activation.

Authors:  Jessica Taaffe; Ann Chahroudi; Jessica Engram; Beth Sumpter; Tracy Meeker; Sarah Ratcliffe; Mirko Paiardini; James Else; Guido Silvestri
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

5.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

6.  Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure.

Authors:  Monica Vaccari; Brandon F Keele; Steven E Bosinger; Melvin N Doster; Zhong-Min Ma; Justin Pollara; Anna Hryniewicz; Guido Ferrari; Yongjun Guan; Donald N Forthal; David Venzon; Claudio Fenizia; Tia Morgan; David Montefiori; Jeffrey D Lifson; Chris J Miller; Guido Silvestri; Margherita Rosati; Barbara K Felber; George N Pavlakis; James Tartaglia; Genoveffa Franchini
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 7.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

8.  Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques.

Authors:  Jacob D Estes; Shari N Gordon; Ming Zeng; Ann M Chahroudi; Richard M Dunham; Silvija I Staprans; Cavan S Reilly; Guido Silvestri; Ashley T Haase
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 9.  Resolution of immune activation defines nonpathogenic SIV infection.

Authors:  Olivier Manches; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

10.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.